Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Expenditures Incurred by Recipients of Biomedical Research and Development Awards From the National Institutes of Health (NIH), 41948-41949 [2020-13522]
Download as PDF
<![CDATA[
41948
Federal Register / Vol. 85, No. 134 / Monday, July 13, 2020 / Notices
Estimated
number of
respondents
Operation
Total ......................................................................................................................................
207,000
respondents
Estimated
time per
response
(in minutes)
Total
burden
hours
5
17,250 hours
2020 Census Post-Enumeration Survey—Revised Estimate
Initial
Initial
Initial
Initial
Housing
Housing
Housing
Housing
Unit
Unit
Unit
Unit
Follow-Up (stateside) ...................................................................................
Follow-Up (PR) .............................................................................................
Follow-up Quality Control (stateside) ...........................................................
Follow-Up Quality Control (PR) ...................................................................
253,800
31,400
38,070
4,710
5
5
5
5
21,150
2,617
3,173
393
Total ......................................................................................................................................
327,980
5
27,333
There are no other proposed changes
to the 2020 Census PES IHUFU field
operation.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view the
Department of Commerce collections
currently under review by OMB.
Written comments and
recommendations for the proposed
information collection should be
submitted within 30 days of the
publication of this notice on the
following website: www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function and
entering either the title of the collection
or the OMB Control Number 0607–1010.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2020–14977 Filed 7–10–20; 8:45 am]
BILLING CODE 3510–07–P
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
jbell on DSKJLSW7X2PROD with NOTICES
Agency Information Collection
Activities; Submission to the Office of
Management and Budget (OMB) for
Review and Approval; Comment
Request; Expenditures Incurred by
Recipients of Biomedical Research
and Development Awards From the
National Institutes of Health (NIH)
The Department of Commerce will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995, on or after the date of publication
of this notice. We invite the general
public and other Federal agencies to
comment on proposed, and continuing
VerDate Sep<11>2014
20:25 Jul 10, 2020
Jkt 250001
information collections, which helps us
assess the impact of our information
collection requirements and minimize
the public’s reporting burden. Public
comments were previously requested
via the Federal Register on April 20,
2020 during a 60-day comment period.
This notice allows for an additional 30
days for public comments.
Agency: Bureau of Economic Analysis
(BEA), Commerce.
Title: Expenditures Incurred by
Recipients of Biomedical Research and
Development Awards from the National
Institutes of Health (NIH).
OMB Control Number: 0608–0069.
Form Number(s): None.
Type of Request: Regular submission,
extension of a current information
collection.
Number of Respondents: 150.
Average Hours per Response: 16
hours is the average but may vary
among respondents because of
differences in institution structure, size,
and complexity.
Burden Hours: 2,400 hours.
Needs and Uses: The survey obtains
the distribution of expenditures
incurred by recipients of biomedical
research awards from the National
Institutes of Health (NIH) and will
provide information on how the NIH
award amounts are expended across
several major categories. This
information, along with wage and price
data from other published sources, will
be used to generate the Biomedical
Research and Development Price Index
(BRDPI). The Bureau of Economic
Analysis (BEA) of the Department of
Commerce develops this index for NIH
under a reimbursable contract. The
BRDPI is an index of prices paid for the
labor, supplies, equipment, and other
inputs required to perform the
biomedical research the NIH supports in
its intramural laboratories and through
its awards to extramural organizations.
The BRDPI is a vital tool for planning
the NIH research budget and analyzing
future NIH programs. A survey of award
PO 00000
Frm 00011
Fmt 4703
Sfmt 4703
recipients is currently the only means
for updating the expenditure category
weights that are used to prepare the
BRDPI.
A survey questionnaire with a cover
letter that includes a brief description
of, and rationale for, the survey will be
sent to potential respondents by August
2020, 2021, and 2022. A report of the
respondent’s expenditures of the NIH
award amounts following the proposed
format for expenditure categories
attached to the survey’s cover letter, will
be requested to be returned no later than
December 8, which in most years will be
approximately 120 days after mailing.
Survey respondents will be selected
based on award levels, which determine
the weight of the respondent in the
biomedical research and development
price index. BEA proposes to survey 150
organizations that receive NIH
biomedical research awards. This will
include the top 100 organizations in
total awards received; 40 additional
organizations that are not primarily in
the ‘‘Research and Development (R&D)
contracts’’ category; and 10 additional
organizations that are primarily in the
‘‘R&D contracts’’ category. Based on
awards data for FY 2019 by type of
organization, the top 100 organizations
received $20.8 billion in awards
(approximately 77 percent of total
awards); the remaining awards-receiving
organizations received $6.1 billion.
Affected Public: Universities or other
organizations that are NIH award
recipients.
Frequency: Annual.
Respondent’s Obligation: Voluntary.
Legal Authority: 45 CFR 75.302,
75.308, 75.361, and 75.364.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view the
Department of Commerce collections
currently under review by OMB.
Written comments and
recommendations for the proposed
information collection should be
submitted within 30 days of the
E:\FR\FM\13JYN1.SGM
13JYN1
Federal Register / Vol. 85, No. 134 / Monday, July 13, 2020 / Notices
publication of this notice on the
following website www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function and
entering either the title of the collection
or the OMB Control Number 0608–0069.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2020–13522 Filed 7–10–20; 8:45 am]
BILLING CODE 3510–06–P
DEPARTMENT OF COMMERCE
International Trade Administration
[A–580–870]
Certain Oil Country Tubular Goods
From the Republic of Korea: Final
Results of Antidumping Duty
Administrative Review; 2017–2018
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) determines that SeAH Steel
Corporation (SeAH), producer/exporter
of certain oil country tubular goods
(OCTG) from the Republic of Korea
(Korea), sold subject merchandise in the
United States at prices below normal
value (NV) during the period of review
(POR) September 1, 2017 through
August 31, 2018, but producer/exporter
Hyundai Steel Company (Hyundai
Steel) did not sell subject merchandise
in the United States below NV during
the POR.
DATES: Applicable July 13, 2020.
FOR FURTHER INFORMATION CONTACT:
Davina Friedmann, AD/CVD
Operations, Office VI, Enforcement and
Compliance, International Trade
Administration, U.S. Department of
Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone:
(202) 482–0698.
SUPPLEMENTARY INFORMATION:
jbell on DSKJLSW7X2PROD with NOTICES
AGENCY:
Background
On November 18, 2019, Commerce
published the Preliminary Results of
this administrative review.1 We invited
interested parties to comment on the
Preliminary Results. Between January 2
and 14, 2020, Commerce received
1 See Certain Oil Country Tubular Goods from the
Republic of Korea: Preliminary Results of
Antidumping Duty Administrative Review; 2017–
2018, 84 FR 63615 (November 18, 2019)
(Preliminary Results), and accompanying Decision
Memorandum.
VerDate Sep<11>2014
20:25 Jul 10, 2020
Jkt 250001
timely filed case and rebuttal briefs from
various interested parties.2 On February
7, 2020, we held a public hearing
concerning the issues raised in the case
and rebuttal briefs.3
On March 12, 2020, we extended the
deadline for the final results.4 On April
24, 2020, Commerce tolled all deadlines
in administrative reviews by 50 days,
thereby extending the deadline for these
results until July 6, 2020.5
These final results cover 32
companies.6 Based on an analysis of the
comments received, we have made
changes to the weighted-average
dumping margins determined for the
respondents. The weighted-average
dumping margins are listed in the
2 See Letter from AJU Besteel Co., Ltd. (AJU
Besteel), ‘‘Certain Oil Country Tubular Goods from
the Republic of Korea—Letter in Support of Case
Briefs,’’ dated January 3, 2020; Letter from the
following Domestic Interested Parties (DIPs):
Maverick Tube Corporation (Maverick), Tenaris Bay
City, Inc. (Tenaris), United States Steel Corporation
(U.S. Steel), TMK IPSCO, Vallourec Star, L.P., and
Welded Tube USA, ‘‘Oil Country Tubular Goods
from the Republic of Korea: Case Brief of Maverick
Tube Corporation and Tenaris Bay City, Inc.,’’ dated
January 3, 2020; Letter from ILJIN Steel Corporation
(ILJIN), ‘‘Oil Country Tubular Goods from the
Republic of Korea: Case Brief,’’ dated January 3,
2020; Letter from SeAH, ‘‘Administrative Review of
the Antidumping Order on Oil Country Tubular
Goods from Korea: Case Brief of SeAH Steel
Corporation,’’ dated January 3, 2020; Letter from
Husteel Co., Ltd. (Husteel), ‘‘Oil Country Tubular
Goods from the Republic of Korea, 9/1/2017–8/31/
2018 Administrative Review, Case No. A–580–870:
Case Brief,’’ dated January 3, 2020; Letter from
NEXTEEL Co., Ltd. (NEXTEEL), ‘‘Oil Country
Tubular Goods from the Republic of Korea:
NEXTEEL’s Letter in Support of Respondents’ Case
Briefs,’’ dated January 3, 2020; Letter from United
States Steel Corporation (U.S. Steel), ‘‘Oil Country
Tubular Goods from the Republic of Korea: Case
Brief of United States Steel Corporation,’’ dated
January 3, 2020; Letter from Hyundai Steel,
‘‘Certain Oil Country Tubular Goods from the
Republic of Korea—Case Brief,’’ dated January 3,
2020; see also Letter from SeAH, ‘‘Administrative
Review of the Antidumping Order on Oil Country
Tubular Goods from Korea—Rebuttal Brief of SeAH
Steel Corporation,’’ dated January 10, 2020; Letter
from DIPs, ‘‘Oil Country Tubular Goods from the
Republic of Korea: Rebuttal Brief of Maverick Tube
Corporation and Tenaris Bay City, Inc.,’’ dated
January 10, 2020; Letter from U.S. Steel, ‘‘Oil
Country Tubular Goods from the Republic of Korea:
Rebuttal Brief of United States Steel Corporation,’’
dated January 10, 2020; and Letter from Hyundai
Steel, ‘‘Certain Oil Country Tubular Goods from the
Republic of Korea—Rebuttal Brief,’’ dated January,
10 2020.
3 See Hearing Transcript from Neal R. Gross and
Co., Inc., filed on ACCESS on February 14, 2020.
4 See Memorandum, ‘‘Certain Oil Country
Tubular Goods from the Republic of Korea:
Extension of Time Limit for Final Results of
Antidumping Duty Administrative Review,’’ dated
March 12, 2020.
5 See Memorandum, ‘‘Tolling of Deadlines for
Antidumping and Countervailing Duty
Administrative Reviews in Response to Operational
Adjustments Due to COVID–19,’’ dated April 24,
2020.
6 The 32 companies consist of two mandatory
respondents and 30 companies not individually
examined.
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
41949
‘‘Final Results of Review’’ section,
below. Commerce conducted this
review in accordance with section
751(a) of the Tariff Act of 1930, as
amended (the Act).
Scope of the Order 7
The merchandise covered by the
Order is certain OCTG, which are
hollow steel products of circular crosssection, including oil well casing and
tubing, of iron (other than cast iron) or
steel (both carbon and alloy), whether
seamless or welded, regardless of end
finish (e.g., whether or not plain end,
threaded, or threaded and coupled)
whether or not conforming to American
Petroleum Institute (API) or non-API
specifications, whether finished
(including limited service OCTG
products) or unfinished (including
green tubes and limited service OCTG
products), whether or not thread
protectors are attached. The scope of the
Order also covers OCTG coupling stock.
For a complete description of the scope
of the Order, see the Issues and Decision
Memorandum.8
Analysis of Comments Received
All issues raised in the case and
rebuttal briefs filed by parties in this
review are addressed in the Issues and
Decision Memorandum. The issues are
identified in Appendix I to this notice.
The Issues and Decision Memorandum
is a public document and is on file
electronically via Enforcement and
Compliance’s Antidumping and
Countervailing Duty Centralized
Electronic Service System (ACCESS).
ACCESS is available to registered users
at https://access.trade.gov. In addition, a
complete version of the Issues and
Decision Memorandum can be accessed
at https://enforcement.trade.gov/frn/
index.html. The signed and electronic
versions of the Issues and Decision
Memorandum are identical in content.
Changes Since the Preliminary Results
Based on our analysis of the
comments received, we made certain
changes to the margin calculations for
SeAH and Hyundai Steel. For a
discussion of these changes, see the
7 See Certain Oil Country Tubular Goods from
India, the Republic of Korea, Taiwan, the Republic
of Turkey, and the Socialist Republic of Vietnam:
Antidumping Duty Orders; and Certain Oil Country
Tubular Goods from the Socialist Republic of
Vietnam: Amended Final Determination of Sales at
Less Than Fair Value, 79 FR 53691 (September 10,
2014) (Order).
8 See Memorandum, ‘‘Issues and Decision
Memorandum for the Final Results of the 2017–
2018 Administrative Review of the Antidumping
Duty Order on Certain Oil Country Tubular Goods
from the Republic of Korea,’’ dated concurrently
with, and hereby adopted by, this notice (Issues and
Decision Memorandum).
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 85, Number 134 (Monday, July 13, 2020)]
[Notices]
[Pages 41948-41949]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13522]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
Agency Information Collection Activities; Submission to the
Office of Management and Budget (OMB) for Review and Approval; Comment
Request; Expenditures Incurred by Recipients of Biomedical Research and
Development Awards From the National Institutes of Health (NIH)
The Department of Commerce will submit the following information
collection request to the Office of Management and Budget (OMB) for
review and clearance in accordance with the Paperwork Reduction Act of
1995, on or after the date of publication of this notice. We invite the
general public and other Federal agencies to comment on proposed, and
continuing information collections, which helps us assess the impact of
our information collection requirements and minimize the public's
reporting burden. Public comments were previously requested via the
Federal Register on April 20, 2020 during a 60-day comment period. This
notice allows for an additional 30 days for public comments.
Agency: Bureau of Economic Analysis (BEA), Commerce.
Title: Expenditures Incurred by Recipients of Biomedical Research
and Development Awards from the National Institutes of Health (NIH).
OMB Control Number: 0608-0069.
Form Number(s): None.
Type of Request: Regular submission, extension of a current
information collection.
Number of Respondents: 150.
Average Hours per Response: 16 hours is the average but may vary
among respondents because of differences in institution structure,
size, and complexity.
Burden Hours: 2,400 hours.
Needs and Uses: The survey obtains the distribution of expenditures
incurred by recipients of biomedical research awards from the National
Institutes of Health (NIH) and will provide information on how the NIH
award amounts are expended across several major categories. This
information, along with wage and price data from other published
sources, will be used to generate the Biomedical Research and
Development Price Index (BRDPI). The Bureau of Economic Analysis (BEA)
of the Department of Commerce develops this index for NIH under a
reimbursable contract. The BRDPI is an index of prices paid for the
labor, supplies, equipment, and other inputs required to perform the
biomedical research the NIH supports in its intramural laboratories and
through its awards to extramural organizations. The BRDPI is a vital
tool for planning the NIH research budget and analyzing future NIH
programs. A survey of award recipients is currently the only means for
updating the expenditure category weights that are used to prepare the
BRDPI.
A survey questionnaire with a cover letter that includes a brief
description of, and rationale for, the survey will be sent to potential
respondents by August 2020, 2021, and 2022. A report of the
respondent's expenditures of the NIH award amounts following the
proposed format for expenditure categories attached to the survey's
cover letter, will be requested to be returned no later than December
8, which in most years will be approximately 120 days after mailing.
Survey respondents will be selected based on award levels, which
determine the weight of the respondent in the biomedical research and
development price index. BEA proposes to survey 150 organizations that
receive NIH biomedical research awards. This will include the top 100
organizations in total awards received; 40 additional organizations
that are not primarily in the ``Research and Development (R&D)
contracts'' category; and 10 additional organizations that are
primarily in the ``R&D contracts'' category. Based on awards data for
FY 2019 by type of organization, the top 100 organizations received
$20.8 billion in awards (approximately 77 percent of total awards); the
remaining awards-receiving organizations received $6.1 billion.
Affected Public: Universities or other organizations that are NIH
award recipients.
Frequency: Annual.
Respondent's Obligation: Voluntary.
Legal Authority: 45 CFR 75.302, 75.308, 75.361, and 75.364.
This information collection request may be viewed at
www.reginfo.gov. Follow the instructions to view the Department of
Commerce collections currently under review by OMB.
Written comments and recommendations for the proposed information
collection should be submitted within 30 days of the
[[Page 41949]]
publication of this notice on the following website www.reginfo.gov/public/do/PRAMain. Find this particular information collection by
selecting ``Currently under 30-day Review--Open for Public Comments''
or by using the search function and entering either the title of the
collection or the OMB Control Number 0608-0069.
Sheleen Dumas,
Department PRA Clearance Officer, Office of the Chief Information
Officer, Commerce Department.
[FR Doc. 2020-13522 Filed 7-10-20; 8:45 am]
BILLING CODE 3510-06-P
